Close Menu

NEW YORK ­– The US Food and Drug Administration said Friday evening that it has reissued an Emergency Use Authorization for Laboratory Corporation of America's COVID-19 RT-PCR Test for testing the broad population, even if they are asymptomatic, and for pooled testing for SARS-CoV-2, the virus that causes COVID-19.

The FDA reissued the EUA for the new uses after LabCorp provided data showing the test could detect SARS-CoV-2 in a general asymptomatic population, the agency said. LabCorp originally received EUA for the test in March.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.